Active cancer therapy combining 13-cis-retinoic acid with interferon-alpha

Editorial

E Dmitrovsky et al. J Natl Cancer Inst. 1992.

. 1992 Feb 19;84(4):218-9.

doi: 10.1093/jnci/84.4.218.

No abstract available

Comment on

13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.
Lippman SM, Parkinson DR, Itri LM, Weber RS, Schantz SP, Ota DM, Schusterman MA, Krakoff IH, Gutterman JU, Hong WK. Lippman SM, et al. J Natl Cancer Inst. 1992 Feb 19;84(4):235-41. doi: 10.1093/jnci/84.4.235. J Natl Cancer Inst. 1992. PMID: 1734084 Clinical Trial.
13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.
Lippman SM, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueño F, Paredes-Casillas P, Hong WK, Holdener E, Krakoff IH. Lippman SM, et al. J Natl Cancer Inst. 1992 Feb 19;84(4):241-5. doi: 10.1093/jnci/84.4.241. J Natl Cancer Inst. 1992. PMID: 1734085 Clinical Trial.